trial

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

NCTId NCT00167934
as of 2026-07-01
at a glance
· Completed
Enrollment 164 (actual)
Primary completion 2008-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Completed
Enrollment
164 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2004-12
Primary completion
2008-12
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Sponsors

Investigators

1
Dan W. Haupt, MDPrincipal Investigator

Sites

1 total
St Louis, United States

Facts & assertions

4 sourced
Enrollment
164
Phase
NA
Primary Completion Date
2008-12
Status
COMPLETED
relationships
The graph out of here
drug
indication
indication
indication
investigator